Merlin Nexus Holds $40 Million Close

Merlin Nexus has held a $40 million first close for its third fund, which is being marketed with a $125 million target. The New York-based firm focuses on late-stage and PIPE opportunities in the life sciences space. Limited Partners include Permal Capital Management and Capital E Group. www.merlinnexus.com